MarginsXMarginsX
Home › Markets › Health Care › BVS

Bioventus Inc. (BVS)

BVS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$10.46
-1.88% on the day
Market cap
$881.4M
Small cap
Revenue · 2025
$568.1M
-0.9% on 2024
Net income · 2025
$22.7M
4.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/0001665988-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBVS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001665988
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$568.1M
Net income$22.7M
Operating income$54.0M
Net margin4.0%
Operating margin9.5%
Revenue growth-0.9%
Cash$51.2M
Total assets$683.6M
P/E (computed)38.8×
P/S (computed)1.6×

Warning signs

Cash runway
Cash-flow positive
$30.7M cash at September 26, 2026
Share count, 1 year
+1.8%
2025-10-31 to 2026-10-23
Going-concern doubt
No
10-Q filed November 2, 2026
Insider net buying, 12 months
-$313K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-02
Cash and burn$30.7M cash; operating cash flow $21.9M a quarter.Report 2026-09-26
Shares outstanding84,260,956 (2026-10-23); 82,763,214 a year earlier.Cover page 2026-10-23
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton LLP, Raleigh, North Carolina, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $313K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-26
$142.4M$6.0M$20.7M$30.7M$229.8M$585.6M10-Q 2026-11-02
Q2 2026
2026-06-27
$153.2M$33.4M$19.9M$29.5M$248.5M$581.8M10-Q 2026-08-05
Q1 2026
2026-03-28
$132.1M$3.1M$8.9M$35.8M$272.1M$576.3M10-Q 2026-05-06
Q4 2025
2025-12-31
$157.9M$14.8M$38.0M$51.2M$294.0M$568.1M10-K 2026-03-05
Q3 2025
2025-09-27
$138.7M$3.2M$30.1M$42.2M$322.6M$563.8M10-Q 2026-11-02
Q2 2025
2025-06-28
$147.7M$7.5M$25.9M$32.9M$341.2M$564.1M10-Q 2026-08-05
Q1 2025
2025-03-29
$123.9M-$2.6M-$19.3M$22.8M$345.9M$567.7M10-Q 2026-05-06
Q4 2024
2024-12-31
$153.6M-$388K$19.3M$41.6M$335.6M$573.3M10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32024-11-04
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-11-02
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 464 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month-21.4%
3 months-23.3%
Year to date+43.3%
1 year+40.8%
From 52-week high-30.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
AORTArtivion Inc.$18.47-3.30%$901.1M
BBNXBeta Bionics Inc.$15.21-7.37%$826.9M
KIDSOrthoPediatrics Corp.$31.50-2.63%$822.5M
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier